BX
Botanix Pharmaceuticals Limited
BXPHF · OTC
$0.02 +0.00% (+$0.00)
1M -35.71%
Market Cap $68.1M
P/E Ratio -
Div. Yield -
ROE 95.70%
Bulios Fair Price
$0.03
66.7% upside
Current Price
$0.018
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BXPHF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
88 /100
Cheap P/B 1.07x
P/S 1.98x
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 40.34%
Rev. growth 109.05%
FCF growth N/A
Profitability
0 /100
Weak Net margin 202.15%
Op. margin 200.82%
FCF margin 187.17%
Quality
4 /100
Poor ROE 95.70%
ROA 65.83%
Asset turnover 0.33x
Debt
69 /100
Low Current ratio 2.59x
Int. coverage -24.43x
Debt/Equity 0.23x
Stability
26 /100
Unstable Rev. volatility 273.32%
EPS volatility 241.39%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BXPHF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Howie McKibbon
Employees
11
Headquarters
Melbourne
Upcoming events
03 MAR
Earnings
Upcoming earnings report